Outcomes of Renal Replacement in Mexico

A descriptive, observational, prospective, multicenter study aimed at describing the main clinical outcomes of patients with chronic kidney disease receiving any form of renal replacement therapy in Mexico.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Chronic Kidney Disease - Stage V Chronic Disease Chronic Kidney Disease on Hemodialysis Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Willingness to participate and provision of written informed consent
Diagnosis of chronic kidney disease and treatment with hemodialysis or peritoneal dialysis for ≥3 months
Availability of a medical record containing information on the study variables
Receiving care at one of the participating centers

Exclusion criteria

Life expectancy <3 months due to a cause unrelated to chronic kidney disease

Treatment and study plan

Primary outcomes

All-cause mortality

Time frame: From enrollment in the study until death from any cause or end of follow-up, assessed up to 3 years.

The occurrence of death from any cause during the follow-up period, as documented in the patient's medical record

Secondary outcomes

Hospitalizations per patient-year

Time frame: From enrollment until the end of follow-up, assessed up to 3 years

The number of hospitalizations recorded during the study follow-up, expressed per patient-year
Infection rate

Time frame: From enrollment until the end of follow-up, assessed up to 3 years

The number of documented infection episodes during the follow-up period, as recorded in the medical records, expressed per patient-year.

Study contacts

Contact information is provided by the study sponsor or research team.

Olynka Vega Vega, MD, MSc

CONTACT

[email protected]

+5215548039428

Yazmin Alejandra Mercado Hernandez, MD

CONTACT

[email protected]

+5215520353821

Sponsors and collaborators

Lead sponsor

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Other

Registry information

Official study title

Clinical Outcomes Study of Mexican Patients With Chronic Kidney Disease on Renal Replacement Therapy

Acronym: ORReMex

Important dates

Study start: 2026
Primary completion: 2026
Study completion: 2029
First posted: Mar 16, 2026
Registry last updated: Mar 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed